Gleneagles Hong Kong

SINGAPORE (Nov 30): Analysts say IHH Healthcare’s 3Q18 headline loss of RM104 million ($34 million) did not come as a surprise, given the 30% q-o-q depreciation of the Turkish lira versus the US dollar.

SINGAPORE (Aug 24): CIMB is maintaining its “add” call on IHH Healthcare with a target price of RM6.99 ($2.22).

SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong

SINGAPORE (Aug 26): UOB Kay Hian is maintaining its “hold” call recommendation on IHH Healthcare, lowering its target price from $2.31 previously to $2.14 as 2Q earnings were dragged down by startup costs of new hospitals as well as higher staff costs